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Acute eosinophilic pneumonia (AEP) can be a challenging diagnosis and is often initially misdiagnosed as
one of the more common pneumonia syndromes such as acute respiratory distress syndrome. Early
bronchoalveolar lavage (BAL) is critical in distinguishing the diagnosis to initiate proper management.
The etiology of AEP is unknown, though many drugs have been implicated, including minocycline.
Minocycline is commonly used for pneumonia, acute bronchitis, urinary tract infections, and acne and
is likely the cause of AEP in our patient. There are 26 case reports of minocycline-induced AEP. In most
cases, outcomes were favorable and symptoms rapidly resolved upon discontinuation of minocycline,
with 11 cases employing steroids, one case twelve hours of CPAP and another 5 days of intubation. None
resulted in mortality. Although it is difﬁcult to evaluate without further studies, steroids should be
recommended for minocycline-induced AEP, especially for those with severe or persistent symptoms.
© 2015 The Author. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Acute eosinophilic pneumonia (AEP) can be a challenging
diagnosis and is often initially misdiagnosed as one of the more
common pneumonia syndromes. Early bronchoalveolar lavage
(BAL) is critical in establishing a diagnosis to initiate proper man-
agement. There have been numerous drugs implicated in the
development of AEP. Twenty-six have been reported in the English
literature. We describe a case consistent with minocycline-induced
eosinophilic pneumonia.2. Case summary
An 87-year-old male initially presented to the emergency
department with right hand cellulitis after being bitten by his pet
dog. Past history included coronary artery disease, TIA, hyperten-
sion, hyperlipidemia, osteoporosis, and glaucoma. He previously
smoked a few cigarettes per day but quit 60 years ago. He denied
any other illicit drug use. One dose of intravenous ampicillin/Center.
td. This is an open access article usulbactam was administered in the emergency department. The
woundwas thoroughly washed. The patient was then discharged to
complete a course of oral amoxicillin/clavulanate. Three days later
hewas seen in orthopedic clinic for follow up. Continued signiﬁcant
erythema, edema, and warmth of the wound and hand were noted
prompting hospitalization. Three days of intravenous ampicillin/
sulbactam and vancomycin were administered with improvement.
He was discharged to complete a 10 day course of oral amoxicillin
875 mg/clavulanate and minocycline. Twelve days after discharge
he presented again to the emergency room for ankle pain after a
misstep. He also described 10e15 loose, non-bloody bowel move-
ments in the 24 h prior to admission. History was otherwise
unremarkable.
Vitals revealed a fever to 102.7 F, hypotension to 90/62, tachy-
cardia at 108 beats per minute, tachypnea to 22 breaths per minute
and an oxygen saturation of 87% while breathing ambient air. On
evaluation he was breathing and speaking comfortably. Faint
crackles were auscultated. A 3/6 systolic murmur loudest at the
apex and a ﬂat JVP were noted. His hand exhibited mild erythema
and an eschar on the dorsal hand without excessive warmth. There
was mild left ankle warmth and edema. Laboratory studies re-
ﬂected a leukocytosis to 20.8 k/uL with 74% neutrophils, 20% lym-
phocytes, and 2.8% eosinophils. Creatinine was slightly elevated atnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Image 2. Computed tomography of the chest revealed diffuse bilateral airspace dis-
ease with ground glass attenuation involving all lobes along with moderate bilateral
pleural effusions.
Image 3. Computed tomography of the chest revealed diffuse bilateral airspace dis-
ease with ground glass attenuation involving all lobes along with moderate bilateral
pleural effusions.
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demonstrated small bilateral effusions and vague bilateral upper
lobe lung inﬁltrates (Image 1). He was diagnosed with an ankle
sprain but was hospitalized for severe sepsis, pneumonia and acute
kidney injury. Intravenous ertapenem, vancomycin, and azi-
thromycin given recent antimicrobial use in addition to oral
metronidazole for possible C. difﬁcile colitis.
Worsening tachypnea and hypoxia developed on hospital day 2
in addition to ongoing fevers. Supplemental oxygen at 4 L per
minute via nasal cannula was required to maintain oxygen satu-
ration in the low 90s. A complete blood count with differential was
obtained demonstrating a new eosinophilia to 22.8% with ongoing
leukocytosis at 17.3 k/uL. Repeat chest ﬁlm revealed interval
worsening of a diffuse alveolar ﬁlling pattern concerning for acute
respiratory distress syndrome. Small bilateral pleural effusions
persisted. Computed tomography of the chest revealed diffuse
bilateral airspace disease with ground glass attenuation involving
all lobes along with moderate bilateral pleural effusions (Images 2
and 3).
The trachea was intubated to permit ﬂexible ﬁberoptic bron-
choscopy given the degree of compromise in hypoxemia and res-
piratory mechanics. BAL and transbronchial biopsies were obtained
from the right side. A trial of liberation frommechanical ventilation
immediately post procedure failed. The patient was reintubated,
and mechanical ventilatory support was initiated. By the next
morning an FiO2 of 0.80was required tomaintain saturations in the
low nineties. A pneumothorax developed in the right hemithorax
and a chest tube was placed. Initial blood cultures identiﬁed
streptococcus parasanguinus in 2 out of 2 specimens. Urine culture
grew >100 K colony forming units of Klebsiella. C. diﬁcile toxin
returned negative without further diarrhea. Urine legionella anti-
gen and coccidiodes IgG and IgM returned negative. Antimicrobials
were tailored to ampicillin/sulbactam and ciproﬂoxacin.
Analysis of the BAL sample revealed 515 nucleated cells per
microliter, of which 6% were neutrophils, 5% lymphocytes, and 15%
eosinophils. Transbronchial biopsies demonstrated marked eosin-
ophilia in both the alveolar and interstitial spaces. Bacterial, fungal,
mycobacterial and viral stains and cultures were negative. Meth-
ylprednisolone was started at 125 mg every 6 h.
The following morning leukocytosis decreased to 13.5 k/uL with
a precipitous drop in eosinophilia to 8.3%. By hospital day six the
patient had defervesced with marked improvement in gas ex-
change. He was successfully liberated from mechanical ventilationImage 1. Admission Chest Radiograph demonstrated small bilateral effusions and
bilateral upper lobe lung inﬁltrates.with supplemental oxygen requirements improving to 3 L per
minute via nasal cannula. There was normalization of eosinophilia
to 0.1% with marked improvement in air space disease on imaging
(Image 4). Solumedrol was transitioned to oral prednisone of 60mg
daily. Ciproﬂoxacin was discontinued as Klebsiella in the urine was
determined to be a contaminant, given urinalysis was negative forImage 4. Three weeks after oral steroid therapy, marked resolution of bilateral in-
ﬁltrates and improvement of bilateral effusions are seen.
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lution of an air leak on hospital day 15. Transthoracic echocardio-
gram revealed no evidence of endocarditis and repeat blood
cultures were sterile. A 14 day course of vancomycinwas completed
for streptococcus parasanguinous bacteremia. After rehabilitation
the patient was discharged on day 30.
3. Discussion
3.1. Demographics
Less than 200 cases of AEP have been reported to date. Themean
age of onset is 29 years [1], with no gender preference. There does
not appear to be a regional predilection. Cases have been reported
throughout the United States (Colorado, Ohio, Kentucky, Massa-
chusetts, Georgia) and all around the world, including Belgium,
France, Japan, and Korea.
3.2. Etiology
The etiology and pathophysiology of AED is unknown. However,
it is postulated that stimuli activate T-lymphocytes which, in turn,
initiate eosinophil accumulation in the lung. There is a developing
body of data implicating cytokines as a mediator. Selective activa-
tion of eosinophils by IL-5 produced by T-lymphocytes may be the
inciting event resulting in eosinophil-rich alveolar exudates [1]. It
has been estimated approximately 40% of patients with AEP have a
history of smoking. It is speculated that recent changes in smoking
habits, such as restarting after cessation, is associated with the
development of AEP [2]. About 66% of patients with AEP are current
smokers [1e3]. In Uchimaya et al., change in smoking habits
correlated with AEP. While all but their 33 AEP patients were
smokers, interestingly 23 (69.7%) had just started smoking within
one month prior to AEP onset [4]. Some patients have reported
unusual outdoor activities including gasoline tank cleaning, cave
exploration, plant repotting, smokehouse cleaning, and motocross
racing prior to the onset of symptoms [3]. Paragonwestermani has
been implicated in one case report as an infectious cause of AEP [5].
Numerous drugs have been associated with eosinophilic pneu-
monia, however fewer drugs have met the clinical criteria for the
syndrome of AEP. These include BCG vaccination [6], daptomycin
[7], minocycline, amiodarone [8], ﬂudarabine, intramuscular pro-
gesterone, sertraline, venlafaxine [9], ibuprofen [10], mesalazine
suppository [11], and marijuana [12].
3.3. Clinical characteristics
In descending order the most common symptoms at presenta-
tion are rapid onset of fever, dyspnea, non-productive cough, and
tachypnea, in previously healthy individuals. A more subacute
presentation over a few weeks has been described. Progression to
life-threatening respiratory failure can occur within a few hours.
Chest pain is present in 73% of patients and is typically pleuritic.
Myalgias are present in approximately half of patients. Crackles are
auscultated in about 80% of patients, with 13% having bothwheezes
and crackles, but 20% of patients are clear [13].Table 1
Revised criteria for the diagnosis of idiopathic acute eosinophilic pneumonia.
Acute of onset of febrile respiratory symptoms 1 month duration
Bilateral diffuse opacities on chest radiography;
Hypoxemia, with PaO2 on room air <60 mmHg, and/or PaO2/FiO2 300 mmHg or room
Lung eosinophilia, with >25% eosinophils on BAL differential cell count, or eosinophili
Absence of infection or other causes of eosinophilic lung disease. Patients generally la
Adapted from Philit et al.3.4. Laboratory ﬁndings
Themost widely used criteria for diagnosis of AEP was proposed
by Philit et al. in their analysis of 22 patients (Table 1). Arterial
oxygen saturation, chest radiograph and BAL are essential for
diagnosis, as are blood, sputum, and BAL cultures to rule-out in-
fectious etiologies. Patients generally lack peripheral blood eosin-
ophilia at presentation. In a case report of 22 patients, meanWBC at
the time of hospitalization was 20.7  109/L with a standard de-
viation of 10.9 while mean peripheral eosinophil count was
0.98  109/L± 1.5 [1]. Patients often present with a neutrophil
predominance, later in the course of hospitalization, peripheral
blood eosinophilia is seen in most patients. In the same study the
percentage of eosinophils on BAL was 53 ± 19%. There is a mixed
cellular inﬁltrate with eosinophils dominating in the BAL, with an
average of 20% lymphocytes and 15% neutrophils [3]. There
generally is not neurophilia or lymphocytosis on BAL in drug-
induced eosinophilic pneumonia. Peripheral blood IgE level can
be either normal or elevated in AEP. Lung biopsy is not essential in
the diagnosis of AEP except for the purpose of excluding other
diseases that may mimic AEP.
3.5. Radiographic ﬁndings
Characteristic radiographic ﬁndings include diffuse inﬁltrates,
Kerley-B lines, and bilateral pleural effusions. Later mixed reticular
and alveolar inﬁltrates can be seen which can progress to densely
alveolar. CT scans in AEP show diffuse interstitial inﬁltrates, patchy
alveolar inﬁltrates, or diffuse ground glass inﬁltrates. Inﬁltrates
will eventually resolve, with bilateral pleural effusions resolving
last.
3.6. Differential diagnosis
Because a majority of patients will meet the diagnostic criteria
for ALI/ARDS it is important to distinguish between these entities.
Several features distinguish AEP from ARDS. AEP is typically not
accompanied by multi-organ failure, although two cases of shock
was were reported [1,14]. Lastly, in ARDS neutrophils are predom-
inant on BAL. Therefore, early BAL is critical in differentiating be-
tween AEP and ALI/ARDS. Moreover, clinicians must obtain samples
from alveoli, rather than a tracheal aspirate or a bronchial washing,
since AEP is an alveolitis. Other considerations in differential
diagnosis includes fungal infections with as Aspergillus and Coc-
cidioides, as well as parasitic infections with Strongyloides.
Other idiopathic eosinophilic pneumonias include simple
eosinophilic pneumonia (Loefﬂer's syndrome) and chronic eosin-
ophilic pneumonia (CEP). CEP was ﬁrst described in 1960 and is
clinically distinguishable from AEP by several characteristics. Pa-
tients with CEP are more likely to have a prior asthma history [15].
Presenting symptoms are similar except onset is insidious over
weeks to months, with the presence of peripheral eosinophilia. The
typical chest radiographic ﬁndings in CEP include peripheral pul-
monary inﬁltrates as opposed to the diffuse inﬁltrates seen in AEP.
While not a prerequisite for diagnosis, BAL can be helpful and
shows an isolated increase in BAL eosinophils, generally more thanair oxygen saturation <90%;
c pneumonia at lung biopsy;
ck peripheral blood eosinophilia
Table 2
Summary of case reports of minocycline-induced AEP.
Age/gender Days until
symptom onset
Steroid use Respiratory
interventions
Rechallenge
test
Lymphocyte
stimulation
Ho [19] 36 M 7e11 days None ND ND
20 F 4 weeks Oral prednisone 40 mg for 1 month ND ND
Otero [20] 55 F 4 weeks Oral prednisone 60 mg, unreported duration ND ND
Yokoyama [21] 30 F 2 weeks None Positive Negative
Bando [22] 65 M 5 days Oral prednisolone 30 mg for 5 days Positive Negative
Sitbom [23] 53 21 days None ND ND
38 5 days None Positive ND
22 21 days None ND ND
36 14 days Yes, unreported details ND ND
28 1 day Yes, unreported details Positive ND
28 10 days None ND ND
17 12 days Yes, unreported details ND ND
43 10 days None Required CPAP ND ND
Dykhuizen [24] 36 F 7 days Oral prednisone 30 mg for 10 days Positive ND
Toyoshima [25] 38 F 8 days Three of the following patients in this study
used short term oral steroids
ND Negative
33 M 8 days ND
84 F 13 days Negative
70 F 4 days Negative
67 F 12 days Negative
75 F 10 days Negative
26 M 6 days Negative
Oddo [26] 54 F 2 weeks IV methylprednisolone for 7 days Required intubation Positive ND
Ono [27] 55 F 1 week None Positive Negative
ND: not done.
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normal percentages.
3.7. Treatment
The majority of patients have a rapid and response to cortico-
steroids, with clinical improvement within 24e48 h. Since
approximately two-thirds of patients require mechanical ventila-
tion, these patients should be admitted to the intensive care unit for
close observation. the optimal dosage of corticosteroids and dura-
tion of administration have not been determined, intravenous
methylprednisolone from 60 to 125 mg every six hours is generally
used with a switch to oral prednisone after clinical improvement
[13]. Oral prednisone was tapered as quickly as 10 days and asTable 3
Summary of signiﬁcant laboratory ﬁndings.
White blood cells at presentation (1000/uL) Peak eosinophilia reported (1
1 2.4 (28%)
2 15.2 (41%)
3 12.9 5.8
4 18.4 2.3 (23%)
5 11.9
6 1.2
7 1.7
8 2.8
9 1.9
10 1.6
11 0.17
12 1.6
13 1.3
14 6.8 1.9 (24%)
15 14.9 (0%)
16 6.4 (8%)
17 10.8 (1%)
18 8.5 (6%)
19 8.2 (3%)
20 9.8 (6%)
21 18.9 (0%)
22 30.0 4.0
23 34 4.2
ND: not done.slowly as 3 months. It has been recommended to taper oral pred-
nisone over 2e6 weeks [2,16,17]. There are some reports of patients
improving spontaneously without corticosteroid treatment [1].
Most patients have complete clinical remission with no long-term
pulmonary sequelae and no residual abnormalities on chest
radiograph. Pulmonary function tests normalize in the majority of
patients, however a minority will have residual mild restrictive
changes. Relapse after steroid cessation is rare, unlike in CEP where
relapse is common once treatment is stopped [3].
4. Conclusion
Minocycline is commonly used for pneumonia, acute bronchitis,
urinary tract infections, and acne and is likely the cause of AEP in000/uL) IgE (IU/mL) Percentage of eosinophils in bronchoalveolar lavage
ND
ND
ND
4%
322 6%
353 27%
1505 50%
ND 55%
137 5%
ND 39%
600 22%
ND 12.5%
3600 ND
807 13.5%
1100 13.5%
3675 ND
2510 12%
20 25.5%
99 35%
ND ND
620 59%
ND present
ND 26.4%
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temporal association, presentation and met diagnostic criteria. 23
case reports of minocycline-induced AEP are summarized in Table 2
and signiﬁcant laboratory ﬁndings in Table 3, with a few cases in
the French and Japanese literature omitted. Mean time from initi-
ation of minocycline to symptom onset was 11 days, with a range of
1 daye4 weeks, while ours was 12 days. Peripheral eosinophilia
was noted in most cases at some point during hospitalization. Time
to peak of peripheral eosinophilia was only noted in six of the 23
cases which varied from hospitalization day 3e15, with our patient
also lacking peripheral eosinophilia until hospital day two. Per-
centage of BAL eosinophilia was 25% ± 17%, reiterating the impor-
tance of early BAL to establish early diagnosis when peripheral
eosinophilia is not yet present. IgE was considered positive in nine
of 13 cases in which it was obtained (1180 ± 1283 IU/mL), with cut-
offs used for positivity varying between 120 and 400 IU/mL.
Outcomes were generally favorable and symptoms rapidly
resolved upon discontinuation of minocycline, with 11 cases
employing steroids, one case twelve hours of CPAP and only one
requiring intubation. None resulted in mortality. Lymphocyte
stimulation was negative in all patients that were done, and thus is
not a useful conﬁrmatory test in minocycline-induced AEP. Mino-
cycline should be avoided in patients who had a history of AEP as all
patients who were re-challenged had a relapse, generally in a
shorter time frame of 1e2 days. Although it is difﬁcult to evaluate
without further studies, steroids should be recommended for
minocycline-induced AEP, especially for those with severe or
persistent symptoms.
While ampicillin has been reported to cause pneumonitis [18], it
has not been reported to be associated to ﬁt the clinical criteria AEP,
nor has vancomycin. Our patient is unlikely to have developed AEP
secondary to the antibiotics he received during his second admis-
sion given his presentation on admission and the timeline of
events.
He was subsequently seen in the pulmonary clinic a month after
discharge. He denied any respiratory symptoms and was started on
a slow three month taper of prednisone. He was also started on
inhaled mometasone to ease prednisone taper.References
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